Exciting survival data for ibrutinib vs placebo in treatment-naïve, early-stage CLL Presented ByDr Petra Langerbeins, University of Cologne, Germany TrialPhase 3, CLL12 ConferenceEHA 2019 9 August, 2019 16:26